Pozen Settles Securities Class Action
Pharmaceutical company Pozen Inc. disclosed Tuesday that it had settled a class action accusing it of artificially inflating its stock price by misleading investors about the approvability of two headache drugs....To view the full article, register now.
Already a subscriber? Click here to view full article